Medicines – Open-house rebate agreements 2026–27 – follitropin delta

Summary

The tender concerns open-house rebate agreements for the medicinal product follitropin delta. Techniker Krankenkasse intends to conclude contracts with all suitable pharmaceutical companies under uniform conditions; there are no individual negotiations and no exclusivity for any contract partner. The contract term is up to 24 months from 1 September 2026 and ends no later than 31 August 2028, or earlier if the patent or market exclusivity expires. Further details must be checked in the participation and contract documents.